4BZR
Human testis angiotensin converting enzyme in complex with K-26
Summary for 4BZR
| Entry DOI | 10.2210/pdb4bzr/pdb |
| Related | 4BZS |
| Descriptor | ANGIOTENSIN-CONVERTING ENZYME, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ACETATE ION, ... (9 entities in total) |
| Functional Keywords | hydrolase, antihypertensive agents, zinc metallopeptidase |
| Biological source | HOMO SAPIENS (HUMAN) |
| Total number of polymer chains | 1 |
| Total formula weight | 70108.13 |
| Authors | Kramer, G.J.,Mohd, A.,Schwager, S.L.U.,Masuyer, G.,Acharya, K.R.,Sturrock, E.D.,Bachmann, B.O. (deposition date: 2013-07-29, release date: 2014-02-26, Last modification date: 2024-10-23) |
| Primary citation | Kramer, G.J.,Mohd, A.,Schwager, S.L.U.,Masuyer, G.,Acharya, K.R.,Sturrock, E.D.,Bachmann, B.O. Interkingdom Pharmacology of Angiotensin-I Converting Enzyme Inhibitor Phosphonates Produced by Actinomycetes Acs Med.Chem.Lett., 5:346-, 2014 Cited by PubMed Abstract: The K-26 family of bacterial secondary metabolites are N-modified tripeptides terminated by an unusual phosphonate analog of tyrosine. These natural products, produced via three different actinomycetales, are potent inhibitors of human angiotensin-I converting enzyme (ACE). Herein we investigate the interkingdom pharmacology of the K-26 family by synthesizing these metabolites and assessing their potency as inhibitors of both the N-terminal and C-terminal domains of human ACE. In most cases, selectivity for the C-terminal domain of ACE is displayed. Co-crystallization of K-26 in both domains of human ACE reveals the structural basis of the potent inhibition and has shown an unusual binding motif that may guide future design of domain-selective inhibitors. Finally, the activity of K-26 is assayed against a cohort of microbially produced ACE relatives. In contrast to the synthetic ACE inhibitor captopril, which demonstrates broad interkingdom inhibition of ACE-like enzymes, K-26 selectively targets the eukaryotic family. PubMed: 24900839DOI: 10.1021/ML4004588 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.84 Å) |
Structure validation
Download full validation report






